OTCMKTS:CVALF Covalon Technologies - CVALF Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Covalon Technologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. $1.60 0.00 (0.00%) (As of 02/1/2023 12:00 AM ET) Add Compare Share Share Today's Range$1.60▼$1.6050-Day Range$1.57▼$1.8152-Week Range$1.26▼$2.14VolumeN/AAverage Volume1,601 shsMarket Capitalization$40.20 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsEarningsHeadlinesShort Interest About Covalon Technologies (OTCMKTS:CVALF) StockCovalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of patent-protected medical products. It focuses on the wound care, infection management, and surgical procedures. The firm sells its products under the brand name Covalon. Its products categories include advanced wound care, vascular access, perioperative care, and urology. The company was founded on April 28, 2004 and is headquartered in Mississauga, Canada.Read More Receive CVALF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Covalon Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address CVALF Stock News HeadlinesJanuary 26, 2023 | msn.comCovalon Technologies GAAP EPS of -$0.16, revenue of $5.39MNovember 29, 2022 | finance.yahoo.comCovalon to Present at the Planet MicroCap Investor Showcase: VIRTUAL 2022 on Wednesday, December 7, 2022February 2, 2023 | Investor Place Media (Ad)Cash Holders STILL Aren't Taking Steps to PrepareStocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.November 21, 2022 | finance.yahoo.comCovalon's SurgiClear Dressing Plays an Important Part in Preventing Surgical Wound Infections at Top Children's HospitalNovember 1, 2022 | finance.yahoo.comClosing Chronic Wounds with Collagen Powder: University of Michigan case study demonstrates the efficacy of ColActive Plus Powder in resolving non-healing woundsSeptember 28, 2022 | finance.yahoo.comCovalon to Participate in the 12th International Pediatric Intestinal Failure and Rehabilitation Symposium in TorontoSeptember 13, 2022 | finance.yahoo.comCovalon to Introduce New Infection Prevention Products at the Annual Association of Pediatric Hematology/Oncology Nurses (APHON) ConferenceAugust 24, 2022 | finance.yahoo.comCovalon Announces Conference Call to Discuss Third Quarter Fiscal 2022 Financial ResultsFebruary 2, 2023 | Investor Place Media (Ad)Cash Holders STILL Aren't Taking Steps to PrepareStocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.June 2, 2022 | finance.yahoo.comA Covalon Technologies Ltd. (CVE:COV) insider increased their holdings by 5.7% last yearApril 28, 2022 | finance.yahoo.comCovalon Technologies Ltd. to Present at the Planet MicroCap Showcase 2022 in Las Vegas on Wednesday, May 4, 2022March 2, 2022 | seekingalpha.comCovalon Technologies Ltd. 2021 Q4 - Results - Earnings Call PresentationFebruary 16, 2022 | finance.yahoo.comCovalon Announces Conference Call to Discuss First Quarter Fiscal 2022 Financial ResultsDecember 24, 2021 | nasdaq.comCovalon CFO Danny Brannagan To Step Down In January 2022December 24, 2021 | finance.yahoo.comCovalon Announces CFO TransitionDecember 13, 2021 | finance.yahoo.comCovalon Announces Strong Year End and Fourth Quarter Results for Fiscal 2021December 8, 2021 | finance.yahoo.comCovalon Announces Conference Call to Discuss Fourth Quarter and Year End Fiscal 2021 Financial ResultsDecember 3, 2021 | finance.yahoo.comCovalon Technologies to Present at the SNN Network Canada Virtual Event on Wednesday, December 8, 2021October 29, 2021 | finance.yahoo.comInvestors in Covalon Technologies (CVE:COV) have made a impressive return of 145% over the past yearSeptember 24, 2021 | finance.yahoo.comCovalon Announces Retirement of Board MemberAugust 26, 2021 | finance.yahoo.comCovalon Announces Conference Call to Discuss Third Quarter Fiscal 2021 Financial ResultsJune 17, 2021 | finance.yahoo.comEstimating The Intrinsic Value Of Covalon Technologies Ltd. (CVE:COV)May 29, 2021 | ca.finance.yahoo.comUPDATE 1-Boeing to pay $17 mln in FAA settlement over 737 MAX, NG equipmentMay 27, 2021 | finance.yahoo.comCovalon Announces Conference Call to Discuss Second Quarter Fiscal 2021 Financial ResultsJanuary 6, 2021 | finance.yahoo.comAging well in Quebec: A portrait of the inequalities between generations and between seniorsJanuary 6, 2021 | finance.yahoo.comWinshear Gold Secures Funding for Legal Proceedings Against the Government of TanzaniaSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive CVALF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Covalon Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address CVALF Company Calendar Today2/02/2023Next Earnings (Estimated)2/27/2023Fiscal Year End9/30/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Health services Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:CVALF CUSIPN/A CIKN/A Webwww.covalon.com Phone(905) 568-8400FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.29) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-7,410,000.00 Net Margins-53.06% Pretax MarginN/A Return on Equity-30.01% Return on Assets-25.25% Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$13.91 million Price / Sales2.89 Cash Flow$0.03 per share Price / Cash Flow46.66 Book Value$1.02 per share Price / Book1.57Miscellaneous Outstanding Shares25,126,000Free FloatN/AMarket Cap$40.20 million OptionableNot Optionable Beta-0.49 Key ExecutivesBrian E. PedlarPresident, Chief Executive Officer & DirectorElaine ZhangVice President-OperationsJason F. GorelChief Financial OfficerValerio DiTizioChief Scientific OfficerHector PadillaVice President-Strategic MarketsKey CompetitorsUpHealthNYSE:UPHBetter TherapeuticsNASDAQ:BTTXP3 Health PartnersNASDAQ:PIIIBabylonNYSE:BBLNXcelerateOTCMKTS:XCRTView All Competitors CVALF Stock - Frequently Asked Questions How have CVALF shares performed in 2023? Covalon Technologies' stock was trading at $1.6490 at the beginning of 2023. Since then, CVALF stock has decreased by 3.0% and is now trading at $1.60. View the best growth stocks for 2023 here. Are investors shorting Covalon Technologies? Covalon Technologies saw a increase in short interest in January. As of January 15th, there was short interest totaling 600 shares, an increase of 500.0% from the December 31st total of 100 shares. Based on an average daily trading volume, of 600 shares, the days-to-cover ratio is currently 1.0 days. View Covalon Technologies' Short Interest. When is Covalon Technologies' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, February 27th 2023. View our CVALF earnings forecast. What is Covalon Technologies' stock symbol? Covalon Technologies trades on the OTCMKTS under the ticker symbol "CVALF." How do I buy shares of Covalon Technologies? Shares of CVALF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Covalon Technologies' stock price today? One share of CVALF stock can currently be purchased for approximately $1.60. How much money does Covalon Technologies make? Covalon Technologies (OTCMKTS:CVALF) has a market capitalization of $40.20 million and generates $13.91 million in revenue each year. The company earns $-7,410,000.00 in net income (profit) each year or ($0.29) on an earnings per share basis. How can I contact Covalon Technologies? Covalon Technologies' mailing address is 1660 Tech Avenue Unit 5, Mississauga A6, L4W 5S7. The official website for the company is www.covalon.com. The company can be reached via phone at (905) 568-8400 or via email at bpedlar@covalon.com. This page (OTCMKTS:CVALF) was last updated on 2/2/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.